Overview
Coronary stent NASH+ with drug coating Everolimus is intended to increase the diameter of the lumen of the coronary vessels in patients with symptoms of coronary heart disease, including patients with acute myocardial infarction and patients with concomitant diabetes mellitus, caused by new-onset local lesions of the native coronary artery.
Specifications
- The ultra-thin thickness of the stent beams (65 µm) reduces the risk of stent thrombosis in the long term
- Ultra-low crossing profile (~1.0 mm) of the stent provides improved flexibility and deliverability
- Increased radial strength of the stent guarantees reliable support of the vascular wall and reduces the risk of recoil (<5%), ensuring a stable result after implantation
- Thin bioresorbable polymer coating with a thickness of 3 microns reduces the risk of developing inflammation of the vessel
- The technology of applying a polymer coating to a stent allows you to maintain the integrity of the polymer coating after expansion of the stent and guarantees controlled systemic release of the drug
- Conductor compatibility: max 0.014’’
- Catheter compatibility: 5F
- NP: 8 ATM
- RBP: 16 ATM
- X-ray contrast markers: Pt-Ir (2 pcs)
- Balloon material: Nylon/Pebax
Resources
Have questions?
We'll find the device
We'll find the device
for your case
Send us a request — a specialist will get back to you about availability, documentation and delivery terms.
Contact us